SEARCH

SEARCH BY CITATION

REFERENCES

  • Abu-Shajran, M., Buskila, D., Ehrenfeld, M., Conrad, K. & Shoenfeld, Y. (2001) Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Annals of Rheumatic Disease, 60, 433441.
  • Adams, B.B. & Mutasim, D.F. (2000) (2000) The diagnostic value of anti-nuclear antibody testing. International Journal of Dermatology, 39, 887891.
  • Ansell, S.M., Grant, C.S. & Habermann, T.M. (1999) Primary thyroid lymphoma. Seminars in Oncology, 26, 316323.
  • Antoine, J.C. & Honnorat, J. (2000) Anti-neuronal antibodies and central nervous system diseases. contribution to diagnosis and pathophysiology. Review of Neurology, 156, 2333.
  • Aozasa, K., Inoue, A., Tajima, K., Miyauchi, A., Matsuzuka, F. & Kuma, K. (1986) Malignant lymphomas of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors. Cancer, 58, 100104.
  • Aozasa, K., Ueda, T., Katagiri, S., Matsuzuka, F., Kuma, K. & Yonezawa, T. (1987) Immunologic and immunohistologic analysis of 27 cases with thyroid lymphomas. Cancer, 60, 969973.
  • Asherson, R.A., Block, S., Houssiau, F.A. & Hughes, G.R. (1991) Systemic lupus erythematosus and lymphoma: association with antiphospholipid syndrome. Journal of Rheumatology, 8, 277279.
  • Barrios, Y., Plaza, A., Cabrera, R. & Diaz-Espada, F. (2000) Autoantibody activity of the immunoglobulin secreted by a follicular B-cell lymphoma. Acta Pathologica, Microbiologica et Immunologica, 108, 764770.
  • Beaufay, H., Amar Costesec, A., Feytmans, E., Thines Sempoux, D., Wibo, M., Robbi, M. & Berthet, J. (1974) Analytical study of microsomes and subcellular membranes from rat liver. I. Biochemical methods. Journal of Cell Biology, 61, 188200.
  • Blaes, F., Klotz, M., Huwer, H., Straub, U., Kalweit, G., Schimrigk, K. & Schafers, H.J. (2000) Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer. Annals of Thoracic Surgery, 69, 254258.
  • Borche, L., Lim, A., Binet, J.L. & Dighiero, G. (1990) Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood, 76, 562569.
  • Casiano, C.A., Humbel, R.L., Peebles, C., Covini, G. & Tan, E.M. (1995) Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. Journal of Autoimmunity, 84, 575586.
  • Chandor, S.B. (1988) Autoimmune phenomena in lymphoid malignancies. Clinical Laboratory Medicine, 8, 373384.
  • Chen, T.R. (1988) Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenetics and Cell Genetics, 48, 1924.
  • Dighiero, G. (1998) Autoimmunity and B-cell malignancies. Hematology and Cell Therapy, 40, 19.
  • Disis, M.L. & Cheever, M.A. (1996) Oncogenic proteins as tumor antigens. Current Opinion in Immunology, 8, 637642.
  • Duhrsen, U., Augener, W., Zwingers, T. & Brittinger, G. (1987) Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. British Journal of Haematology, 67, 235239.
  • Fabien, N., Moreira, A., Lavergne, J.P., Reboud, J.P., Desbos, A., Perrier, H., Venot, A., Bargis, P., Vard, C., Bienvenu, J. & Monier, J.C. (1999) Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the PO, P1 and P2 proteins. Journal of Autoimmunity, 13, 103110.
  • Fernandez-Madrid, F. & Tomkiel, J. (2000) Antinuclear antibodies as potential markers of lung cancer. In: Cancer and Autoimmunity (ed. by Y.Shoenfeld & M.E. Gershwin), pp. 151158. Elsevier Science.
  • Fleischmann, M., Celerier, P., Bernard, P., Litoux, P. & Dreno, B. (1996) Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology, 192, 5055.
  • Gadol, N. & Ault, K.A. (1986) Phenotypic and functional characterization of human Leu1 (CD5) B cells. Immunological Review, 93, 2334.
  • Granel, B., Bouabdallah, R., Serratrice, J., Swiader, L., Veit, V.V., Horschowski, N., Xerri, L., Disdier, P. & Weiller, P. (2001) Prelymphomatous presentation of T-cell non-Hodgkin lymphomas. A clinical and histopathological study of 11 cases. European Journal of Internal Medicine, 12, 5759.
  • Gronbaek, K., D'amore, F. & Schmidt, K. (1995) Autoimmune phenomena in non-Hodgkin's lymphoma. Leukemia and Lymphoma, 18, 311316.
  • Gronbaek, K., Straten, P.T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M.K., Hansen, N.E., Zeuthen, J., Hou Jensen, K. & Guldberg, P. (1998) Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood, 92, 30183024.
  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 13611392.
  • Hollingsworth, P.N., Dawkins, R.I. & Peter, J.B. (1996) Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution. Clinical and Diagnostic Laboratory Immunology, 3, 374377.
  • Huminer, D., Tomer, Y., Pitlick, S. & Shoenfeld, Y. (1990) Autoantibodies in cancer patients: are they tumor related or age related. Autoimmunity, 5, 232233.
  • Jonsson, V., Wiik, A., Hou-Jensen, K., Christiansen, M., Ryder, L.P., Madsen, H.O., Geisler, C., Hansen, M.M., Thomsen, K., Vorstrup, S. & Svejgaard, A. (1999) Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. Journal of Internal Medicine, 245, 277286.
  • Levine, A.M. (1994) Lymphoma complicating immunodeficiency disorders. Annals of Oncology, 5, 2935.
  • McCurley, T.L., Collins, R.D., Ball, E. & Collins, R.D. (1990) Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome. a clinical and immunopathologic study. Human Pathology, 21, 482492.
  • Mariette, X. (1999) Lymphomas in patients with Sjogren's syndrome: review of the literature and physiopathologic hypothesis. Leukemia and Lymphoma, 33, 9399.
  • Mellemkjaer, L., Andersen, V., Linet, M.S., Grideley, G., Hoover, R. & Olsen, J.H. (1997) Non Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematous. Arthritis and Rheumatism, 40, 761768.
  • Montenarh, M., Harlozinska, A., Bar, J.K., Kartarius, S., Gunther, J. & Sedlaczek, P. (1998) p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer. International Journal of Oncology, 13, 605610.
  • Ortiz-Hidalgo, C. & Wright, T.D. (1992) .H. The morphological spectrum of monocytoid B-cell lymphoma and its relationship to lymphomas of mucosa-associated lymphoid tissue. Histopathology, 21, 555561.
  • Pasquinelli, C., Bhavani, K. & Chisari, F.V. (1992) Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Research, 52, 28232829.
  • Penin, F., Godinot, C., Comte, J. & Gautheron, D.C. (1982) Vesicular preparation of a highly coupled ATPase-ATP synthase complex from pig heart mitochondria. Biochimica et Biophysica Acta, 679, 198209.
  • Peterson, S.R., Talpur, R. & Duvic, M. (1998) Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology, 39, 434438.
  • Polliack, A. & Lugassy, G. (1992) Autoimmunity and auto–immune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia, 6, 152154.
  • Rattner, J.B., Rao, A., Fritzler, M.J., Valencia, D.W. & Yen, T.J. (1993) CENP-F is a 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cellular Motility Cytoskeleton, 26, 214226.
  • Rattner, J.B., Rees, J., Whitehead, C.M., Casiano, C.A., Tan, E.M., Humbel, R.L., Conrad, K. & Fritzler, M.J. (1997) High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clinical Investigation of Medicine, 20, 308319.
  • Rattner, J.B., Mack, G.J. & Fritzler, M.J. (1998) Autoantibodies to components of the mitotic apparatus. Molecular Biology Reports, 25, 143155.
  • Reeves, W.H. (2001) Tumor immunity and autoimmunity: a case of Dr Jekyll and Mr Hyde. Clinical Immunology, 100, 129133.
  • Rodenburg, R.J., Raats, J.M., Pruijn, G.J. & Van Venrooij, W.J. (2000) Cell death: a trigger of autoimmunity. Bioassays, 22, 627636.
  • Rovere, P., Fazzini, F., Sabbadini, M.G. & Manfredi, A.A. (2000) Apoptosis and systemic autoimmunity: the dendritic cell connection. European Journal of Histochemistry, 44, 229236.
  • Rustin, M.H., Isenberg, D.A., Griffiths, M.H. & Gilkes, J.J. (1988) Sjogren's syndrome and pleomorphic T-cell lymphoma presenting with skin involvement. Journal of the Royal Society of Medicine, 81, 4749.
  • Sallah, S., Sigounas, G., Vos, P., Wan, J.Y. & Nguyen, N.P. (2000) Autoimmune lymphocytic anemia in patients with non Hodgkin's lymphoma: characteristics and significance. Annals of Oncology, 11, 15711577.
  • Sato, S., Fujimoto, M., Ihn, H. & Takehara, K. (1994) Antibodies to centromere and centriole in scleroderma spectrum disorders. Dermatology, 189, 2326.
  • Stockert, E., Jager, E., Chen, Y.T., Scanlan, M.J., Gout, I., Karbach, J., Arand, M., Knuth, A. & Old, L.J. (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. Journal of Experimental Medicine, 187, 13491354.
  • Swissa, M., Cohen, Y. & Schoenfeld, Y. (1992) Autoantibodies in the sera of patients with lymphoma. Leukemia and Lymphoma, 7, 117122.
  • Syrigos, K.N., Charalambopoulos, A., Pliarchopoulou, K., Varsamidakis, N., Machairas, A. & Mandrekas, D . (2000) The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma. Anticancer Research, 20, 43514353.
  • Tamura, K., Shimaoka, K. & Friedman, M. (1981) Thyroid abnormalities associated with treatment of malignant lymphoma. Cancer, 47, 27042711.
  • Timuragaoglu, A., Dumain, A., Ongut, G., Saka, O. & Karadogan, I. (2000) The significance of autoantibodies in non-Hodgkin's lymphoma. Leukemia and Lymphoma, 40, 119122.
  • Tiplady, C.W., Hamilton, P.J. & Galloway, M.J. (2000) Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine. Clinical Laboratory Haematology, 22, 163165.
  • Torchilin, V.P., Iakoubov, L.Z. & Estrov, Z. (2001) Antinuclear autoantibodies as potential antineoplastic agents. Trends in Immunology, 22, 424427.
  • Tuffanelli, D.L., McKeon, F., Kleinsmith, D.M., Burnham, T.K. & Kirschner, M. (1983) Anticentromere and anticentriole antibodies in the scleroderma spectrum. Archives of Dermatology, 119, 560566.
  • Tursi, A. & Gasbarrini, G. (1999) Acquired gastric mucosa-associated lymphoid tissue (MALT): a review with special emphasis on association with extragastric diseases and management problems of gastric MALT. Journal of Clinical Gastroenterology, 29, 133137.
  • Wasserman, J., Glas, U. & Blomgren, H. (1975) Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. Clinical and Experimental Immunology, 19, 417422.
  • Winter, S.F., Minna, J.D., Johnson, B.E., Takahashi, T., Gazdar, A.F. & Carbone, D.P. (1992) Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Research, 52, 41684174.
  • Xavier, R.M., Yamauchi, Y., Nakamura, M., Tanigawa, Y., Ishikura, H., Tsunematsu, T. & Kobayashi, S. (1995) Antinuclear antibodies in healthy aging people: a prospective study. Mechanisms of Ageing and Development, 78, 145154.
  • Youinou, P., Mackenzie, L.E., Lamour, A., Magged, R.A. & Lydyard, P.M. (1993) Human CD-positive b cells in lymphoid malignancy and connective tissue diseases. European Journal of Clinical Investigation, 23, 139150.
  • Zhang, J.Y., Chan, E.K.L., Peng, X.X., Lu, M., Wang, X., Mueller, F. & Tan, E.M. (2001a) Autoimmune responses to mRNA binding proteins p62 and Kox in diverse malignancies. Clinical Immunology, 100, 149156.
  • Zhang, J.Y., Zhu, W., Imai, H., Kiyosawa, K., Chan, E.K. & Tan, E.M. (2001b) De novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Clinical and Experimental Immunology, 125, 39.